Our proprietary technology offers the fastest and most cost-efficient approach to hit identification that allows for serendipity and delivers high quality hits.
Access a unique DEL technology that allows to add a truly novel chemical space to your DEL screening decks.
Benefit from serendipity in hit ID with a breakthrough DEL technology that offers lower hit attrition and lower follow-up costs.
START-UPS & RESEARCH ORGANISATIONS
Save time and budget by screening DELs that are designed for your target proteins.
Get ready to take hit ID in drug discovery to the next level! Serengen and Deargen have partnered up to integrate their DEL and AI platforms for a faster, more affordable and effective drug discovery.
I agree that the information I supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679.